INCY News and Press, Incyte Corporation

Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolio Both INCB161734, an investigational, potent, selective and orally bioavailable KRAS G12D inhibitor, and INCA33890 1 , a TGFβR2×PD-1 bispecific antibody, are being eval...

- Treatment with latarcibart led to an 81% median reduction in annualized bleeding rate (ABR) across all bleeding categories and patient types with von Willebrand disease (VWD) - Latarcibart, administered via a once monthly subcutaneous dosing regimen, was shown to be safe and well tole...

2026-07-08 20:25:00 ET Incyte (NASDAQ: INCY) and TG Therapeutics (NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for its work in Janus kinase (JAK) inhibition, f...

2026-07-06 12:15:00 ET More on ARK Invest The Higher They Climb: 3 Non-Chip ETFs Exposed To An AI Stock Meltdown Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update ARKQ: AI's Renaissance Lifting Cathie Wood's Autonomous Tech & Robotics ETF (Rating U...

Acquisition adds VGA039, a novel investigational monoclonal antibody in Phase 3 development for patients with von Willebrand disease (VWD), strengthening Incyte’s late-stage pipeline Incyte (Nasdaq:INCY) announced today it has completed its acquisition of Vega Therapeutics, Inc...

2026-07-02 11:53:49 ET More on the markets June Jobs Report: Weak Hiring Or Fewer Workers? U.S. Rate Hike Talk Cools On Softer Jobs Data Meta Might Have Just Popped The AI Bubble Dow, S&P 500 get a lift from weaker-than-expected payrolls lowering odds of ...

2026-07-02 07:00:00 ET ... Read the full article on Seeking Alpha For further details see: Top 10 Quant Stocks Of 2026 Up Nearly 70%

2026-06-29 08:35:54 ET INCY Remains A Great Long Pick Last week, Incyte Corporation ( INCY ) stock closed above its previous swing high, as traders call the local highs, gaining about 16% in a single trading week while the broader market was going through a noticeable sell-off of ov...

2026-06-28 09:05:16 ET More on State Street Health Care Select Sector SPDR ETF AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit Merck's Bio-Techne buyout put Life Sciences sector in focus: ...

2026-06-26 12:22:12 ET More on Eli Lilly, Johnson & Johnson, etc. Johnson & Johnson: Not Every Dollar Needs To Chase The AI Boom (Upgrade) AbbVie Inc. (ABBV) Apogee Therapeutics, Inc. - M&A Call - Slideshow AbbVie Inc. (ABBV) M&A Call Transcript ...